{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:22:00Z","timestamp":1783606920442,"version":"3.55.0"},"reference-count":32,"publisher":"Bioscientifica","issue":"6","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:p>Aldosterone-producing adenoma (APA) is one of the major causes of primary aldosteronism (PA). Although 68Ga-pentixafor PET\/CT has emerged as a promising tool for subtyping diagnosis of PA, its diagnostic efficacy in distinguishing APA from non-functional adrenal adenoma (NFA) remains to be evaluated. To evaluate the value of 68Ga-pentixafor PET\/CT in differentiating APA from NFA, this study prospectively included patients suspicious of APA and patients diagnosed with NFA to undergo 68Ga-pentixafor PET\/CT. APA was further confirmed by post-surgery histopathology and biochemical results. The diagnostic efficacy of visual analysis, maximum standardized uptake value (SUVmax) of adrenal lesions, and lateralization index of SUVmax (LI) was analyzed by receiver operating characteristic (ROC) curve. The cohort included 75 patients with APA and 51 patients with NFA. Visual analysis achieved an area under the ROC curve (AUC) of 0.84, with a sensitivity and a specificity of 0.95 and 0.73, respectively. The AUC for SUVmax and LI was 0.96 and 0.93, respectively. At an LI cutoff of 1.65, the sensitivity and specificity were both 0.87. Using an SUVmax cutoff of 7.0, the sensitivity and specificity reached 0.88 and 0.85, respectively. Visual analysis revealed a higher false-positive rate (27.27%) compared to LI (12.73%) and SUVmax (14.55%). 68Ga-pentixafor PET\/CT is useful in differentiating APA from NFA; however, false-positive results remain a concern, particularly with visual analysis.<\/jats:p>","DOI":"10.1530\/erc-25-0371","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:31:15Z","timestamp":1779298275000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["The diagnostic value of 68Ga-pentixafor PET\/CT in differentiating adrenal aldosterone-producing adenomas from non-functional adenomas"],"prefix":"10.1530","volume":"33","author":[{"given":"Shu","family":"Cheng","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlin","family":"Kuang","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangshuang","family":"Zhang","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jing","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Shen","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Li","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlong","family":"Li","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Hu","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqiang","family":"Ma","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Pang","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifu","family":"Li","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-4779","authenticated-orcid":true,"given":"Shumin","family":"Yang","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"2026070909473632500_bib1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026070909473632500_bib2","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026070909473632500_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/joim.12831","article-title":"Diagnosis and treatment of primary aldosteronism: practical clinical perspectives","volume":"285","author":"Young","year":"2019","journal-title":"J Intern Med"},{"key":"2026070909473632500_bib4","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909473632500_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension"},{"key":"2026070909473632500_bib6","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","article-title":"Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism","volume":"47","author":"Ding","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070909473632500_bib7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00330-022-09058-x","article-title":"Functional nodules in primary aldosteronism: identification of CXCR4 expression with (68)Ga-pentixafor PET\/CT","volume":"33","author":"Gao","year":"2022","journal-title":"Eur Radiol"},{"key":"2026070909473632500_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55609","article-title":"Accuracy of Gallium-68 pentixafor positron emission tomography-computed tomography for subtyping diagnosis of primary aldosteronism","volume":"6","author":"Hu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026070909473632500_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/clinem\/dgad421","article-title":"The value of targeting CXCR4 with 68Ga-Pentixafor PET\/CT for subtyping primary aldosteronism","volume":"109","author":"Zheng","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909473632500_bib10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.7326\/M22-1619","article-title":"Prevalence and characteristics of adrenal tumors in an unselected screening population : a cross-sectional study","volume":"175","author":"Jing","year":"2022","journal-title":"Ann Intern Med"},{"key":"2026070909473632500_bib11","first-page":"267","article-title":"[Preliminary study on the ability of (68)Ga-Pentixafor PET\/CT to differentiate between adrenal aldosterone-producing adenoma and nonfunctional adenoma]","volume":"62","author":"Gao","year":"2023","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2026070909473632500_bib12","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMc070612","article-title":"The incidentally discovered adrenal mass","volume":"356","author":"Pacak","year":"2007","journal-title":"N Engl J Med"},{"key":"2026070909473632500_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.38209","article-title":"Corticotropin stimulation in adrenal venous sampling for patients with primary aldosteronism: the ADOPA randomized clinical trial","volume":"6","author":"Yang","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026070909473632500_bib14","first-page":"1","article-title":"Age-related cutoffs of plasma aldosterone\/renin concentration for primary aldosteronism screening","volume":"2018","author":"Ma","year":"2018","journal-title":"Int J Endocrinol"},{"key":"2026070909473632500_bib15","doi-asserted-by":"crossref","first-page":"e2449","DOI":"10.1210\/clinem\/dgaa282","article-title":"Development and validation of criteria for sparing confirmatory tests in diagnosing primary aldosteronism","volume":"105","author":"Wang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909473632500_bib16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension"},{"key":"2026070909473632500_bib17","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1210\/clinem\/dgz150","article-title":"Diagnosis of primary aldosteronism by seated saline suppression test-variability between immunoassay and HPLC-MS\/MS","volume":"105","author":"Thuzar","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909473632500_bib18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070909473632500_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909473632500_bib20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/RLU.0000000000004244","article-title":"Usefulness of 68 Ga-Pentixafor PET\/CT on diagnosis and management of Cushing syndrome","volume":"47","author":"Ding","year":"2022","journal-title":"Clin Nucl Med"},{"key":"2026070909473632500_bib21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12020-024-04024-7","article-title":"Typing diagnostic value of 68Ga-pentixafor PET\/CT for patients with primary aldosteronism and unilateral nodules","volume":"87","author":"Zuo","year":"2024","journal-title":"Endocrine"},{"key":"2026070909473632500_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cen.15204","article-title":"Clinical utility of dual-time 68Ga-Pentixafor PET\/CT in diagnosing and subtyping primary aldosteronism","volume":"102","author":"Zuo","year":"2025","journal-title":"Clin Endocrinol"},{"key":"2026070909473632500_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2018.06.028","article-title":"Comparison of SUVmax and SUVpeak based segmentation to determine primary lung tumour volume on FDG PET-CT correlated with pathology data","volume":"129","author":"Mercieca","year":"2018","journal-title":"Radiother Oncol"},{"key":"2026070909473632500_bib24","doi-asserted-by":"crossref","first-page":"e2583","DOI":"10.1210\/clinem\/dgae747","article-title":"Comparison of different diagnostic criteria of 68Ga-Pentixafor PET\/CT for the classification of primary aldosteronism","volume":"110","author":"Zhang","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909473632500_bib25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/JU.0000000000001752","article-title":"Partial adrenalectomy carries a considerable risk of incomplete cure in primary aldosteronism","volume":"206","author":"van de Wiel","year":"2021","journal-title":"J Urol"},{"key":"2026070909473632500_bib26","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJMc2213180","article-title":"CXCR4 antagonist in HPV5-Associated perianal squamous-cell carcinoma","volume":"390","author":"Marin-Esteban","year":"2024","journal-title":"New Engl J Med"},{"key":"2026070909473632500_bib27","first-page":"411","article-title":"CXCR4 chemokine antagonist scores a first FDA approval for WHIM syndrome","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"2026070909473632500_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-025-02522-2","article-title":"CXCR4-modification enhances CAR-T efficacy by improving tumor tracking and bone marrow homing in B-cell malignancies","volume":"11","author":"Shu","year":"2026","journal-title":"Signal Transduct Tar"},{"key":"2026070909473632500_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1756-9966-29-16","article-title":"Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis","volume":"29","author":"Liu","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"2026070909473632500_bib30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-pharmtox-010919-023340","article-title":"The CXCL12\/CXCR4\/ACKR3 axis in the tumor microenvironment: Signaling, crosstalk, and therapeutic targeting","volume":"61","author":"Smit","year":"2021","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2026070909473632500_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.qai.0000163027.47147.2e","article-title":"Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients","volume":"39","author":"Wolday","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026070909473632500_bib32","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/33\/6\/ERC-25-0371.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/33\/6\/ERC-25-0371.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0371\/519897\/erc-25-0371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0371\/519897\/erc-25-0371.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:47:48Z","timestamp":1783604868000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/6\/e250371\/77569\/The-diagnostic-value-of-68Ga-pentixafor-PET-CT-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0371","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"article-number":"e250371"}}